These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 32687695)

  • 1. Effects of ABCB1, UGT1A1, and UGT1A9 Genetic Polymorphisms on the Pharmacokinetics of Sitafloxacin Granules in Healthy Subjects.
    Sun LN; Sun GX; Yang YQ; Shen Y; Huang FR; Xie LJ; Cheng J; Zhang HW; Zhang XH; Liu Y; Wang YQ
    Clin Pharmacol Drug Dev; 2021 Jan; 10(1):57-67. PubMed ID: 32687695
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Meta-Analysis of Noncompartmental Pharmacokinetic Parameters of Ertugliflozin to Evaluate Dose Proportionality and UGT1A9 Polymorphism Effect on Exposure.
    Marshall JC; Liang Y; Sahasrabudhe V; Tensfeldt T; Fediuk DJ; Zhou S; Krishna R; Dawra VK; Wood LS; Sweeney K
    J Clin Pharmacol; 2021 Sep; 61(9):1220-1231. PubMed ID: 33813736
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics and safety of sitafloxacin after single oral doses in healthy volunteers.
    Wu G; Wu L; Hu X; Zhou H; Liu J; Zhu M; Zheng Y; Zhai Y; Shentu J
    Int J Clin Pharmacol Ther; 2014 Dec; 52(12):1037-44. PubMed ID: 25250613
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of UDP-Glucuronosyltransferase Polymorphisms on Mycophenolic Acid Metabolism in Renal Transplant Patients.
    Xu C; Jiang Z; Qian M; Zuo L; Xue H; Hu N
    Transplant Proc; 2024; 56(6):1280-1289. PubMed ID: 39054222
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sorafenib is an inhibitor of UGT1A1 but is metabolized by UGT1A9: implications of genetic variants on pharmacokinetics and hyperbilirubinemia.
    Peer CJ; Sissung TM; Kim A; Jain L; Woo S; Gardner ER; Kirkland CT; Troutman SM; English BC; Richardson ED; Federspiel J; Venzon D; Dahut W; Kohn E; Kummar S; Yarchoan R; Giaccone G; Widemann B; Figg WD
    Clin Cancer Res; 2012 Apr; 18(7):2099-107. PubMed ID: 22307138
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of genetic variation in UGT1A and ABCB1 on moxifloxacin pharmacokinetics in South African patients with tuberculosis.
    Naidoo A; Ramsuran V; Chirehwa M; Denti P; McIlleron H; Naidoo K; Yende-Zuma N; Singh R; Ngcapu S; Chaudhry M; Pepper MS; Padayatchi N
    Pharmacogenomics; 2018 Jan; 19(1):17-29. PubMed ID: 29210323
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of multidrug resistance gene-1 (ABCB1) polymorphisms on the single-dose pharmacokinetics of cloxacillin in healthy adult Chinese men.
    Yin OQ; Tomlinson B; Chow MS
    Clin Ther; 2009 May; 31(5):999-1006. PubMed ID: 19539100
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic linkage of UGT1A7 and UGT1A9 polymorphisms to UGT1A1*6 is associated with reduced activity for SN-38 in Japanese patients with cancer.
    Fujita K; Ando Y; Nagashima F; Yamamoto W; Eodo H; Araki K; Kodama K; Miya T; Narabayashi M; Sasaki Y
    Cancer Chemother Pharmacol; 2007 Sep; 60(4):515-22. PubMed ID: 17406868
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polymorphisms of UGT1A9 and UGT2B7 influence the pharmacokinetics of mycophenolic acid after a single oral dose in healthy Chinese volunteers.
    Guo D; Pang LF; Han Y; Yang H; Wang G; Tan ZR; Zhang W; Zhou HH
    Eur J Clin Pharmacol; 2013 Apr; 69(4):843-9. PubMed ID: 23052409
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Single and Multiple Ascending-dose Studies of Oral Delafloxacin: Effects of Food, Sex, and Age.
    Hoover R; Hunt T; Benedict M; Paulson SK; Lawrence L; Cammarata S; Sun E
    Clin Ther; 2016 Jan; 38(1):39-52. PubMed ID: 26581327
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Population pharmacokinetics of oxcarbazepine active metabolite in Chinese paediatric epilepsy patients and its application in individualised dosage regimens.
    Lin WW; Li XW; Jiao Z; Zhang J; Rao X; Zeng DY; Lin XH; Wang CL
    Eur J Clin Pharmacol; 2019 Mar; 75(3):381-392. PubMed ID: 30456415
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differences in UGT1A1, UGT1A7, and UGT1A9 polymorphisms between Uzbek and Japanese populations.
    Maeda H; Hazama S; Shavkat A; Okamoto K; Oba K; Sakamoto J; Takahashi K; Oka M; Nakamura D; Tsunedomi R; Okayama N; Mishima H; Kobayashi M
    Mol Diagn Ther; 2014 Jun; 18(3):333-42. PubMed ID: 24453052
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transporter and metabolizer gene polymorphisms affect fluoroquinolone pharmacokinetic parameters.
    Annisa N; Barliana MI; Santoso P; Ruslami R
    Front Pharmacol; 2022; 13():1063413. PubMed ID: 36588725
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of genetic variants in UGT1A1, SLCO1B3, ABCB1, ABCC2, ABCG2, ORM1 on PK/PD of telmisartan in Chinese patients with mild to moderate essential hypertension
.
    Pei Q; Yang L; Tan HY; Liu SK; Liu Y; Huang L; Li RH; Wan Q; Huang J; Guo CX; Zuo XC; Li J; Yang GP
    Int J Clin Pharmacol Ther; 2017 Aug; 55(8):659-665. PubMed ID: 28518053
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A randomized phase I study to evaluate the safety, tolerability, pharmacokinetics and food-effect of Iguratimod in healthy adult volunteers.
    Xiao F; Zhang F; Zhang LL; Wei W
    Eur J Clin Pharmacol; 2018 Jan; 74(1):69-77. PubMed ID: 29051989
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between pharmacokinetics of lenvatinib in healthy subjects and genetic polymorphisms of
    Song H; Bai W; Sun X; Qiu B; Guo N; Guo C; Hu Y; Dong Z
    Xenobiotica; 2021 Dec; 51(12):1463-1469. PubMed ID: 34979850
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional characterization of low-prevalence missense polymorphisms in the UDP-glucuronosyltransferase 1A9 gene.
    Olson KC; Dellinger RW; Zhong Q; Sun D; Amin S; Spratt TE; Lazarus P
    Drug Metab Dispos; 2009 Oct; 37(10):1999-2007. PubMed ID: 19589876
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Haplotypes of variants in the UDP-glucuronosyltransferase1A9 and 1A1 genes.
    Innocenti F; Liu W; Chen P; Desai AA; Das S; Ratain MJ
    Pharmacogenet Genomics; 2005 May; 15(5):295-301. PubMed ID: 15864130
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of ABCB1 Genotypes on the Pharmacokinetics and Clinical Outcomes of New Oral Anticoagulants: A Systematic Review and Meta-analysis.
    Xie Q; Xiang Q; Mu G; Ma L; Chen S; Zhou S; Hu K; Zhang Z; Cui Y; Jiang J
    Curr Pharm Des; 2018; 24(30):3558-3565. PubMed ID: 30338730
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lack of genetic association between OCT1, ABCB1, and UGT2B7 variants and morphine pharmacokinetics.
    Nielsen LM; Sverrisdóttir E; Stage TB; Feddersen S; Brøsen K; Christrup LL; Drewes AM; Olesen AE
    Eur J Pharm Sci; 2017 Mar; 99():337-342. PubMed ID: 28063968
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.